Ibotta, Inc.

IBTA

Find Out if You Qualify for a Financial Reward by filling out the form below.

Ibotta, Inc. Form












Stock Fraud Law Center does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

Ibotta disclosed its financial results for the second quarter on August 13, 2024, marking its first report since its initial public offering (IPO), revealing a net loss of $34.0 million, which constitutes 39% of its revenue for the period. The company reported a 19% decline in direct-to-consumer redemptions on a year-over-year basis, accompanied by a 7% reduction in the number of direct-to-consumer redeemers. Furthermore, the total number of redemptions per redeemer exhibited a notable year-over-year decrease of 39%. Additionally, the revenue generated per redemption exhibited a year-over-year decline over 19%.

Active Cases

Ticker Symbol Company Name Join Deadline Join
APLT Applied Therapeutics, Inc. February 18, 2025 Join
BIOA BioAge Labs, Inc. March 10, 2025 Join
PCRX Pacira BioSciences, Inc. March 14, 2025 Join
NVO Novo Nordisk A/S March 25, 2025 Join
GO Grocery Outlet Holding Corp. March 31, 2025 Join
NEM Newmont Corporation April 01, 2025 Join
GSK GSK plc April 07, 2025 Join
NTLA Intellia Therapeutics, Inc. April 14, 2025 Join
MRK Merck & Co., Inc. April 14, 2025 Join